- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
Sichuan Huiyu Pharmaceutical
Market Cap: CN¥10.0b
Research and develops, produces, and sells anti-tumor and injection drugs in China and internationally.
688553
CN¥23.76
7D
-7.6%
1Y
121.0%
Laekna
Market Cap: HK$5.4b
An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.
2105
HK$12.82
7D
-6.3%
1Y
148.4%
Lipella Pharmaceuticals
Market Cap: US$2.8m
A clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
LIPO
US$0.61
7D
-4.7%
1Y
-85.0%
ICON
Market Cap: US$13.0b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$162.53
7D
-9.4%
1Y
-43.2%
BioPorto
Market Cap: DKK 586.5m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.29
7D
-1.5%
1Y
-29.9%
Siegfried Holding
Market Cap: CHF 3.4b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 78.20
7D
-7.6%
1Y
-32.7%
Imunon
Market Cap: US$12.9m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$5.19
7D
1.8%
1Y
-60.6%
genOway Société anonyme
Market Cap: €29.3m
A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.
ALGEN
€3.18
7D
12.4%
1Y
-17.2%
Biomea Fusion
Market Cap: US$122.6m
A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States.
BMEA
US$2.05
7D
-1.4%
1Y
-78.6%
InterCure
Market Cap: ₪233.3m
Engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
INCR
₪4.95
7D
-3.8%
1Y
-30.4%
Canopy Growth
Market Cap: CA$617.7m
Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.
WEED
CA$1.92
7D
-0.5%
1Y
-68.6%
Mirum Pharmaceuticals
Market Cap: US$3.7b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$73.57
7D
-2.3%
1Y
90.1%
Xencor
Market Cap: US$746.8m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.
XNCR
US$10.33
7D
3.0%
1Y
-49.5%
MaaT Pharma
Market Cap: €63.3m
A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.
MAAT
€3.93
7D
-4.1%
1Y
-47.3%
IGC Pharma
Market Cap: US$37.2m
A clinical stage pharmaceutical company, develops treatments for Alzheimer’s disease in the United States and Colombia.
IGC
US$0.39
7D
-5.1%
1Y
11.7%
BICO Group
Market Cap: SEK 1.5b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 20.64
7D
-4.3%
1Y
-51.9%
BiomX
Market Cap: US$14.1m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
PHGE
US$0.52
7D
2.2%
1Y
-51.4%
MetaVia
Market Cap: US$25.4m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$1.00
7D
9.0%
1Y
-69.6%
YD Bio
Market Cap: US$1.2b
A biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.
YDES
US$14.25
7D
-26.2%
1Y
26.5%
Alzinova
Market Cap: SEK 127.9m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 1.23
7D
6.6%
1Y
-64.2%
Level Bio
Market Cap: SEK 22.2m
Manufactures and distributes cutting-edge solutions in the Nordic region and internationally.
LEVBIO
SEK 0.32
7D
-1.8%
1Y
-24.7%
Traws Pharma
Market Cap: US$13.1m
A clinical-stage biopharmaceutical company, develops small-molecule oral product candidates for respiratory viral diseases and cancer.
TRAW
US$1.88
7D
-8.7%
1Y
-69.2%
Vinci Gen
Market Cap: zł3.2m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
VGN
zł0.30
7D
-16.2%
1Y
-40.0%
ExpreS2ion Biotech Holding
Market Cap: SEK 45.2m
A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.
EXPRS2
SEK 17.00
7D
-2.3%
1Y
-54.9%
Ionis Pharmaceuticals
Market Cap: US$10.2b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$62.97
7D
2.0%
1Y
53.2%
eXoZymes
Market Cap: US$122.5m
Operates as a development stage biotechnology company.
EXOZ
US$14.57
7D
5.9%
1Y
n/a
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret
Market Cap: ₺1.9b
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.
RTALB
₺3.71
7D
1.9%
1Y
17.4%
Prelude Therapeutics
Market Cap: US$69.1m
A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.
PRLD
US$1.22
7D
20.8%
1Y
-44.8%
ODI Pharma
Market Cap: SEK 27.3m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 1.49
7D
2.1%
1Y
-67.6%
Vivoryon Therapeutics
Market Cap: €42.9m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.64
7D
-2.6%
1Y
-31.5%
Innate Pharma
Market Cap: €149.3m
Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
IPH
€1.62
7D
-2.8%
1Y
-17.9%
Pfizer
Market Cap: US$137.0b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$23.60
7D
-2.3%
1Y
-18.5%
Gilead Sciences
Market Cap: US$141.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$110.99
7D
-2.3%
1Y
33.7%
UBI Pharma
Market Cap: NT$1.7b
UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.
6562
NT$14.25
7D
1.8%
1Y
-62.3%
Kanabo Group
Market Cap: UK£1.4m
A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.
KNB
UK£0.0022
7D
0%
1Y
-82.0%
Source Natural Foods and Herbal Supplements
Market Cap: ₹914.0m
Manufactures and sells ayurveda, health and dietary supplements, and food products in India.
531398
₹138.40
7D
0.07%
1Y
-31.3%